COMMUNIQUÉS West-GlobeNewswire

Phase 1 Clinical Data for SYS6002 (CRB-701) to be presented at 2024 ASCO GU

23/01/2024 - 14:00

NORWOOD, Mass., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), announced today that the abstract for the first-in-human Phase 1 dose escalation study [...]

MedBright AI’s MedMatrix to Expand Its AI Offerings for Cosmetic Marketing & Clinical Trial Analytics

23/01/2024 - 14:00

VANCOUVER, British Columbia, Jan. 23, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) is pleased to announce that Rejuvenation, a prominent [...]

IAOMT Position Paper Examines the Science of Jawbone Cavitations Just Ahead of the Yankee Dental Congress!

23/01/2024 - 13:45

LAKELAND, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- The International Academy of Oral Medicine and Toxicology (IAOMT) is pleased to announce the publication of its new position paper on Human Jawbone Cavitations . This [...]

Locus Biosciences Announces $23.9 Million in Funding from BARDA to Support First Phase 2 Trial of CRISPR-engineered Bacteriophage Therapy

23/01/2024 - 13:30

ELIMINATE trial is evaluating LBP-EC01 for treating urinary tract infections caused by drug-resistant E. coli Funding to support advancement into Part 2 of ELIMINATE trial RESEARCH TRIANGLE PARK, N.C., Jan. 23, 2024 ( [...]

Zevra Therapeutics Appoints Experienced Biopharma Executive Alvin Shih, MD, MBA, to the Board of Directors

23/01/2024 - 13:30

CELEBRATION, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced the appointment of Alvin Shih, MD, MBA, to the [...]

iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research

23/01/2024 - 13:30

Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Services LEXINGTON, Mass., Jan. 23, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an [...]

Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application

23/01/2024 - 13:30

FDA continues to review the file past the Prescription Drug User Fee Act goal date of January 22, 2024 MONTREAL, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH [...]

Theratechnologies reçoit une mise à jour de la FDA concernant son supplément à la licence de produit biologique pour la formulation F8 de la tésamoréline

23/01/2024 - 13:30

La FDA continue d'examiner le dossier après la date butoir du Prescription Drug User Fee Act fixée au 22 janvier 2024 MONTRÉAL, 23 janv. 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « [...]

ONL Therapeutics to Present on ONL1204 in Podium Presentation at the 47th Annual Meeting of the Macula Society

23/01/2024 - 13:00

The presentation will review study population data from ONL’s Phase 2 study of ONL1204 Ophthalmic Solution in patients with Macula-Off Rhegmatogenous Retinal Detachment ANN ARBOR, Mich., Jan. 23, 2024 (GLOBE NEWSWIRE [...]

Oxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturing

23/01/2024 - 13:00

Oxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturing Oxford, UK – 23 January 2024: On Wednesday 7 February, Oxford Biomedica, a quality and innovation-led cell and [...]

First Wave BioPharma to Present at the DealFlow MicroCap Conference

23/01/2024 - 13:00

BOCA RATON, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of [...]

Axsome Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20

23/01/2024 - 13:00

NEW YORK, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, [...]

Grow Up Conference & Expo Announces Top 50 Cannabis Leaders in Canada Ahead of CannaVision '24 Executive Summit

23/01/2024 - 13:00

Leading cannabis event company celebrates national leaders and launches an exclusive gathering for decision-makers in the global arena Toronto, ON, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Grow Up Conference & Expo (“Grow [...]

A Cut Above: RIFF Cannabis Brand Expands Its Diamond Collection With New THCA ‘Liquid Diamond’ Vapes

23/01/2024 - 13:00

New RIFF Cannabis Collection Includes Diamond-Infused Multi-Packs of Pre-Rolls and Blunts TORONTO, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading [...]

ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP

23/01/2024 - 12:50

BAUDETTE, Minn., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Pentoxifylline Extended-Release (ER) Tablets, USP 400mg. ANI’s [...]

CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics

23/01/2024 - 12:30

Collaboration to accelerate research to determine role of GBA gene CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner [...]

Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2023

23/01/2024 - 12:24

Company Announcement Net sales of DARZALEX ® in 2023 totaled USD 9,744 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN, Denmark; January 23, 2024 – Genmab A/S ( [...]

CDR-Life Announces FDA Clearance of IND Application for CDR404 for Treatment of Solid Tumors

23/01/2024 - 11:00

First-of-its-kind, antibody-based, bivalent and bispecific MAGE-A4 T-cell engager ZURICH, Switzerland, Jan. 23, 2024 (GLOBE NEWSWIRE) -- CDR-Life Inc. today announced the clearance of an Investigational New Drug (IND) [...]

HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq

23/01/2024 - 10:20

HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq 1st institutional round for HEPHAISTOS-Pharma, getting on track to bring its lead product ONCO-Boost [...]